HNSBF - Hansa Biopharma AB (Publ) (HNSBF) CEO Søren Tulstrup On Q3 2021 Results - Earnings Call Transcript
Hansa Biopharma AB (publ) (HNSBF) Q3 2021 Earnings Conference Call October 21, 2021, 08:00 AM ET Company Participants Klaus Sindahl - Head of Investor Relations Søren Tulstrup - President & Chief Executive Officer Donato Spota - Chief Financial Officer Conference Call Participants Christopher Uhde - SEB Dominic Rose - Intron Health Zoe Karamanoli - RBC Capital Markets Douglas Tsao - H.C. Wainwright Disclaimer*: This transcript is designed to be used alongside the freely available audio recording on this page. Timestamps within the transcript are designed to help you navigate the audio should the corresponding text be unclear. The machine-assisted output provided is partly edited and is designed as a guide. Presentation Operator 00:04 Ladies and gentlemen, welcome to the Hansa Biopharma Q3 Earnings Calls. For the first part of this call, all participants will be in listen-only mode. And afterwards, there will be a question-and-answer session Today, I'm pleased to
For further details see:
Hansa Biopharma AB (Publ) (HNSBF) CEO Søren Tulstrup On Q3 2021 Results - Earnings Call Transcript